Advertisement

Marijuana and electronic cigarettes on cardiac arrhythmias

  • Robert A. Kloner
    Correspondence
    Address reprint requests and correspondence: Dr Robert A. Kloner, Huntington Medical Research Institutes, 686 South Fair Oaks Avenue, Pasadena, CA 91105.
    Affiliations
    Huntington Medical Research Institutes, Pasadena, California

    Keck School of Medicine at University of Southern California, Los Angeles, California
    Search for articles by this author
Published:November 14, 2022DOI:https://doi.org/10.1016/j.hrthm.2022.09.022
      Marijuana use has continued to increase since the legalization of the substance by many states. It is estimated that by the end of 2022, 52 million Americans will have used marijuana. As of August 2022, 38 states either decriminalized cannabis or authorized its use for medical or recreational adult use. Physicians must become aware of not only potential medical benefits but also potential medical dangers of this substance. Potential benefits, including those of synthetic cannabinoids, include reduction of severe nausea and vomiting related to cancer chemotherapy, improvements in certain types of pain, reduction in seizures in certain syndromes of young children, reduction of anorexia in adult patients with AIDS, and reduction of spasticity associated with multiple sclerosis. There are no well-established and clinically accepted benefits of marijuana on the cardiovascular system, although some studies suggest possible benefits in heart failure and preclinical studies suggest a reduction of ischemia/reperfusion injury.
      • Page R.L.
      • Allen L.A.
      • Kloner R.A.
      • et al.
      Medical marijuana, recreational cannabis, and cardiovascular health: a statement from the American Heart Association.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Page R.L.
        • Allen L.A.
        • Kloner R.A.
        • et al.
        Medical marijuana, recreational cannabis, and cardiovascular health: a statement from the American Heart Association.
        Circulation. 2020; 142: e131-e152
        • Rezkalla S.
        • Kloner R.A.
        Cardiovascular effects of marijuana.
        Trends Cardiovasc Med. 2019; 29: 403-407
        • Kariyanna P.T.
        • Wengrofsky P.
        • Jayarangaiah A.
        • et al.
        Marijuana and cardiac arrhythmias: a scoping study.
        Int J Clin Res Trials. 2019; 4: 132
        • Yeniocak S.
        • Kalkan A.
        • Yamanoglu A.
        • Ozturk S.
        • Sogut O.
        • Metiner M.
        The effects of synthetic cannabinoids on the cardiovascular system: a case-control study.
        Turk J Emerg Med. 2021; 21: 198-204
        • Yahud E.
        • Pual G.
        • Rahkovich M.
        • et al.
        Cannabis induced cardiac arrhythmias: a case series.
        Eur Heart J Case Rep. 2020; 4: 1-9
        • Jaladi P.R.
        • Patel V.
        • Rajan S.K.
        • et al.
        Arrhythmia-related hospitalization and comorbid cannabis use disorder: trend analysis in US hospitals (2010–2014).
        Cureus. 2019; 11e5607
        • Gillett L.
        • Johnson-Sasso C.
        • Miller B.
        • Shakowski C.
        • Walker L.A.
        • Tompkins C.
        Arrhythmic effects of cannabis in ischemic heart disease.
        Cannabis Cannabinoid Res. 2022 Mar 29; https://doi.org/10.1089/can.2021.0188
        • Adegbala O.
        • Adejumo A.C.
        • Olakanmi O.
        • et al.
        Relation of cannabis use and atrial fibrillation among patients hospitalized for heart failure.
        Am J Cardiol. 2018; 122: 129-134
        • Lam R.P.K.
        • Tang M.H.Y.
        • Leung S.C.
        • Chong Y.K.
        • Tsui M.S.H.
        • Mak T.W.L.
        Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations.
        Clin Toxicol (Phila). 2017; 55: 662-667
        • Seri A.
        • Rattanawong P.
        • Firouzbakht T.
        • Sorajja D.
        Vaping tetrahydrocannabinol unmasks Brugada pattern and induces ventricular fibrillation in Brugada syndrome: a case report.
        Eur Heart J Case Rep. 2022 Jun 6; 6: ytac200
        • Peruzzi M.
        • Biondi-Zoccai G.
        • Carnevale R.
        • Cavarretta E.
        • Frati G.
        • Versaci F.
        Vaping cardiovascular health risks: an updated umbrella review.
        Curr Emeg Hops Med Rep. 2020; 8: 103-109
        • Demir V.
        • Hidayet S.
        • Turan Y.
        • Ede H.
        Acute effects of electronic cigarette smoking on ventricular repolarization in adults.
        Afr Health Sci. 2020; 20: 1793-1799
        • Abouassali O.
        • Chang M.
        • Chidipi B.
        • et al.
        In vitro and in vivo cardiac toxicity of flavored electronic nicotine delivery systems.
        Am J Physiol Heart Circ Physiol. 2021; 320: H133-H143
      1. Qui H, Zhang H, Han DD, et al. Increased vulnerability to atrial and ventricular arrhythmias caused by different types of inhaled tobacco or marijuana products. Heart Rhythm 202X;XX:XXX–XXX.

      Linked Article